Report Overview
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market size was estimated at USD 5492 million in 2023 and is projected to reach USD 8022.12 million by 2032, exhibiting a CAGR of 4.30% during the forecast period.
North America Parkinsons Disease Drug market size was estimated at USD 1538.49 million in 2023, at a CAGR of 3.69% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Parkinsons Disease Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinsons Disease Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinsons Disease Drug market in any manner.
Global Parkinsons Disease Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Market Segmentation (by Type)
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market Segmentation (by Application)
Hospital
Clinics
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parkinsons Disease Drug Market
Overview of the regional outlook of the Parkinsons Disease Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parkinsons Disease Drug
1.2 Key Market Segments
1.2.1 Parkinsons Disease Drug Segment by Type
1.2.2 Parkinsons Disease Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Parkinsons Disease Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Parkinsons Disease Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Parkinsons Disease Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Parkinsons Disease Drug Market Competitive Landscape
3.1 Global Parkinsons Disease Drug Sales by Manufacturers (2019-2025)
3.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinsons Disease Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Parkinsons Disease Drug Sales Sites, Area Served, Product Type
3.6 Parkinsons Disease Drug Market Competitive Situation and Trends
3.6.1 Parkinsons Disease Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinsons Disease Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Parkinsons Disease Drug Industry Chain Analysis
4.1 Parkinsons Disease Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parkinsons Disease Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Parkinsons Disease Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinsons Disease Drug Sales Market Share by Type (2019-2025)
6.3 Global Parkinsons Disease Drug Market Size Market Share by Type (2019-2025)
6.4 Global Parkinsons Disease Drug Price by Type (2019-2025)
7 Parkinsons Disease Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinsons Disease Drug Market Sales by Application (2019-2025)
7.3 Global Parkinsons Disease Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2025)
8 Parkinsons Disease Drug Market Consumption by Region
8.1 Global Parkinsons Disease Drug Sales by Region
8.1.1 Global Parkinsons Disease Drug Sales by Region
8.1.2 Global Parkinsons Disease Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinsons Disease Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinsons Disease Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinsons Disease Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinsons Disease Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinsons Disease Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Parkinsons Disease Drug Market Production by Region
9.1 Global Production of Parkinsons Disease Drug by Region (2019-2025)
9.2 Global Parkinsons Disease Drug Revenue Market Share by Region (2019-2025)
9.3 Global Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Parkinsons Disease Drug Production
9.4.1 North America Parkinsons Disease Drug Production Growth Rate (2019-2025)
9.4.2 North America Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Parkinsons Disease Drug Production
9.5.1 Europe Parkinsons Disease Drug Production Growth Rate (2019-2025)
9.5.2 Europe Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Parkinsons Disease Drug Production (2019-2025)
9.6.1 Japan Parkinsons Disease Drug Production Growth Rate (2019-2025)
9.6.2 Japan Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Parkinsons Disease Drug Production (2019-2025)
9.7.1 China Parkinsons Disease Drug Production Growth Rate (2019-2025)
9.7.2 China Parkinsons Disease Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Teva
10.1.1 Teva Parkinsons Disease Drug Basic Information
10.1.2 Teva Parkinsons Disease Drug Product Overview
10.1.3 Teva Parkinsons Disease Drug Product Market Performance
10.1.4 Teva Business Overview
10.1.5 Teva Parkinsons Disease Drug SWOT Analysis
10.1.6 Teva Recent Developments
10.2 Novartis AG
10.2.1 Novartis AG Parkinsons Disease Drug Basic Information
10.2.2 Novartis AG Parkinsons Disease Drug Product Overview
10.2.3 Novartis AG Parkinsons Disease Drug Product Market Performance
10.2.4 Novartis AG Business Overview
10.2.5 Novartis AG Parkinsons Disease Drug SWOT Analysis
10.2.6 Novartis AG Recent Developments
10.3 GSK
10.3.1 GSK Parkinsons Disease Drug Basic Information
10.3.2 GSK Parkinsons Disease Drug Product Overview
10.3.3 GSK Parkinsons Disease Drug Product Market Performance
10.3.4 GSK Parkinsons Disease Drug SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 AbbVie
10.4.1 AbbVie Parkinsons Disease Drug Basic Information
10.4.2 AbbVie Parkinsons Disease Drug Product Overview
10.4.3 AbbVie Parkinsons Disease Drug Product Market Performance
10.4.4 AbbVie Business Overview
10.4.5 AbbVie Recent Developments
10.5 Merck
10.5.1 Merck Parkinsons Disease Drug Basic Information
10.5.2 Merck Parkinsons Disease Drug Product Overview
10.5.3 Merck Parkinsons Disease Drug Product Market Performance
10.5.4 Merck Business Overview
10.5.5 Merck Recent Developments
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Parkinsons Disease Drug Basic Information
10.6.2 Boehringer Ingelheim Parkinsons Disease Drug Product Overview
10.6.3 Boehringer Ingelheim Parkinsons Disease Drug Product Market Performance
10.6.4 Boehringer Ingelheim Business Overview
10.6.5 Boehringer Ingelheim Recent Developments
10.7 Impax Laboratories
10.7.1 Impax Laboratories Parkinsons Disease Drug Basic Information
10.7.2 Impax Laboratories Parkinsons Disease Drug Product Overview
10.7.3 Impax Laboratories Parkinsons Disease Drug Product Market Performance
10.7.4 Impax Laboratories Business Overview
10.7.5 Impax Laboratories Recent Developments
10.8 Lundbeck
10.8.1 Lundbeck Parkinsons Disease Drug Basic Information
10.8.2 Lundbeck Parkinsons Disease Drug Product Overview
10.8.3 Lundbeck Parkinsons Disease Drug Product Market Performance
10.8.4 Lundbeck Business Overview
10.8.5 Lundbeck Recent Developments
10.9 Sun Pharma
10.9.1 Sun Pharma Parkinsons Disease Drug Basic Information
10.9.2 Sun Pharma Parkinsons Disease Drug Product Overview
10.9.3 Sun Pharma Parkinsons Disease Drug Product Market Performance
10.9.4 Sun Pharma Business Overview
10.9.5 Sun Pharma Recent Developments
10.10 Wockhardt
10.10.1 Wockhardt Parkinsons Disease Drug Basic Information
10.10.2 Wockhardt Parkinsons Disease Drug Product Overview
10.10.3 Wockhardt Parkinsons Disease Drug Product Market Performance
10.10.4 Wockhardt Business Overview
10.10.5 Wockhardt Recent Developments
10.11 UCB
10.11.1 UCB Parkinsons Disease Drug Basic Information
10.11.2 UCB Parkinsons Disease Drug Product Overview
10.11.3 UCB Parkinsons Disease Drug Product Market Performance
10.11.4 UCB Business Overview
10.11.5 UCB Recent Developments
10.12 Bausch Health
10.12.1 Bausch Health Parkinsons Disease Drug Basic Information
10.12.2 Bausch Health Parkinsons Disease Drug Product Overview
10.12.3 Bausch Health Parkinsons Disease Drug Product Market Performance
10.12.4 Bausch Health Business Overview
10.12.5 Bausch Health Recent Developments
10.13 Acadia
10.13.1 Acadia Parkinsons Disease Drug Basic Information
10.13.2 Acadia Parkinsons Disease Drug Product Overview
10.13.3 Acadia Parkinsons Disease Drug Product Market Performance
10.13.4 Acadia Business Overview
10.13.5 Acadia Recent Developments
11 Parkinsons Disease Drug Market Forecast by Region
11.1 Global Parkinsons Disease Drug Market Size Forecast
11.2 Global Parkinsons Disease Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinsons Disease Drug Market Size Forecast by Country
11.2.3 Asia Pacific Parkinsons Disease Drug Market Size Forecast by Region
11.2.4 South America Parkinsons Disease Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Parkinsons Disease Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Parkinsons Disease Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Parkinsons Disease Drug by Type (2025-2032)
12.1.2 Global Parkinsons Disease Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Parkinsons Disease Drug by Type (2025-2032)
12.2 Global Parkinsons Disease Drug Market Forecast by Application (2025-2032)
12.2.1 Global Parkinsons Disease Drug Sales (K MT) Forecast by Application
12.2.2 Global Parkinsons Disease Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinsons Disease Drug Market Size Comparison by Region (M USD)
Table 5. Global Parkinsons Disease Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Parkinsons Disease Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2022)
Table 10. Global Market Parkinsons Disease Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Parkinsons Disease Drug Sales Sites and Area Served
Table 12. Manufacturers Parkinsons Disease Drug Product Type
Table 13. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinsons Disease Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinsons Disease Drug Market Challenges
Table 22. Global Parkinsons Disease Drug Sales by Type (K MT)
Table 23. Global Parkinsons Disease Drug Market Size by Type (M USD)
Table 24. Global Parkinsons Disease Drug Sales (K MT) by Type (2019-2025)
Table 25. Global Parkinsons Disease Drug Sales Market Share by Type (2019-2025)
Table 26. Global Parkinsons Disease Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global Parkinsons Disease Drug Market Size Share by Type (2019-2025)
Table 28. Global Parkinsons Disease Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global Parkinsons Disease Drug Sales (K MT) by Application
Table 30. Global Parkinsons Disease Drug Market Size by Application
Table 31. Global Parkinsons Disease Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2025)
Table 33. Global Parkinsons Disease Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global Parkinsons Disease Drug Market Share by Application (2019-2025)
Table 35. Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global Parkinsons Disease Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2025)
Table 38. North America Parkinsons Disease Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe Parkinsons Disease Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Parkinsons Disease Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America Parkinsons Disease Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Parkinsons Disease Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global Parkinsons Disease Drug Production (K MT) by Region (2019-2025)
Table 44. Global Parkinsons Disease Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Parkinsons Disease Drug Revenue Market Share by Region (2019-2025)
Table 46. Global Parkinsons Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Parkinsons Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Parkinsons Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Parkinsons Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Parkinsons Disease Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Teva Parkinsons Disease Drug Basic Information
Table 52. Teva Parkinsons Disease Drug Product Overview
Table 53. Teva Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Teva Business Overview
Table 55. Teva Parkinsons Disease Drug SWOT Analysis
Table 56. Teva Recent Developments
Table 57. Novartis AG Parkinsons Disease Drug Basic Information
Table 58. Novartis AG Parkinsons Disease Drug Product Overview
Table 59. Novartis AG Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Novartis AG Business Overview
Table 61. Novartis AG Parkinsons Disease Drug SWOT Analysis
Table 62. Novartis AG Recent Developments
Table 63. GSK Parkinsons Disease Drug Basic Information
Table 64. GSK Parkinsons Disease Drug Product Overview
Table 65. GSK Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. GSK Parkinsons Disease Drug SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. AbbVie Parkinsons Disease Drug Basic Information
Table 70. AbbVie Parkinsons Disease Drug Product Overview
Table 71. AbbVie Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. AbbVie Business Overview
Table 73. AbbVie Recent Developments
Table 74. Merck Parkinsons Disease Drug Basic Information
Table 75. Merck Parkinsons Disease Drug Product Overview
Table 76. Merck Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Merck Business Overview
Table 78. Merck Recent Developments
Table 79. Boehringer Ingelheim Parkinsons Disease Drug Basic Information
Table 80. Boehringer Ingelheim Parkinsons Disease Drug Product Overview
Table 81. Boehringer Ingelheim Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Recent Developments
Table 84. Impax Laboratories Parkinsons Disease Drug Basic Information
Table 85. Impax Laboratories Parkinsons Disease Drug Product Overview
Table 86. Impax Laboratories Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Impax Laboratories Business Overview
Table 88. Impax Laboratories Recent Developments
Table 89. Lundbeck Parkinsons Disease Drug Basic Information
Table 90. Lundbeck Parkinsons Disease Drug Product Overview
Table 91. Lundbeck Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Lundbeck Business Overview
Table 93. Lundbeck Recent Developments
Table 94. Sun Pharma Parkinsons Disease Drug Basic Information
Table 95. Sun Pharma Parkinsons Disease Drug Product Overview
Table 96. Sun Pharma Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Sun Pharma Business Overview
Table 98. Sun Pharma Recent Developments
Table 99. Wockhardt Parkinsons Disease Drug Basic Information
Table 100. Wockhardt Parkinsons Disease Drug Product Overview
Table 101. Wockhardt Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Wockhardt Business Overview
Table 103. Wockhardt Recent Developments
Table 104. UCB Parkinsons Disease Drug Basic Information
Table 105. UCB Parkinsons Disease Drug Product Overview
Table 106. UCB Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. UCB Business Overview
Table 108. UCB Recent Developments
Table 109. Bausch Health Parkinsons Disease Drug Basic Information
Table 110. Bausch Health Parkinsons Disease Drug Product Overview
Table 111. Bausch Health Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Bausch Health Business Overview
Table 113. Bausch Health Recent Developments
Table 114. Acadia Parkinsons Disease Drug Basic Information
Table 115. Acadia Parkinsons Disease Drug Product Overview
Table 116. Acadia Parkinsons Disease Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Acadia Business Overview
Table 118. Acadia Recent Developments
Table 119. Global Parkinsons Disease Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Parkinsons Disease Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Parkinsons Disease Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Parkinsons Disease Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Parkinsons Disease Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Parkinsons Disease Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Parkinsons Disease Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Parkinsons Disease Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Parkinsons Disease Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Parkinsons Disease Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Parkinsons Disease Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Parkinsons Disease Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Parkinsons Disease Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Parkinsons Disease Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Parkinsons Disease Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Parkinsons Disease Drug Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Parkinsons Disease Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Parkinsons Disease Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinsons Disease Drug Market Size (M USD), 2019-2032
Figure 5. Global Parkinsons Disease Drug Market Size (M USD) (2019-2032)
Figure 6. Global Parkinsons Disease Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinsons Disease Drug Market Size by Country (M USD)
Figure 11. Parkinsons Disease Drug Sales Share by Manufacturers in 2023
Figure 12. Global Parkinsons Disease Drug Revenue Share by Manufacturers in 2023
Figure 13. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinsons Disease Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinsons Disease Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinsons Disease Drug Market Share by Type
Figure 18. Sales Market Share of Parkinsons Disease Drug by Type (2019-2025)
Figure 19. Sales Market Share of Parkinsons Disease Drug by Type in 2023
Figure 20. Market Size Share of Parkinsons Disease Drug by Type (2019-2025)
Figure 21. Market Size Market Share of Parkinsons Disease Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinsons Disease Drug Market Share by Application
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2025)
Figure 25. Global Parkinsons Disease Drug Sales Market Share by Application in 2023
Figure 26. Global Parkinsons Disease Drug Market Share by Application (2019-2025)
Figure 27. Global Parkinsons Disease Drug Market Share by Application in 2023
Figure 28. Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2025)
Figure 30. North America Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 32. U.S. Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Parkinsons Disease Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Parkinsons Disease Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 37. Germany Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Parkinsons Disease Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Parkinsons Disease Drug Sales Market Share by Region in 2023
Figure 44. China Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Parkinsons Disease Drug Sales and Growth Rate (K MT)
Figure 50. South America Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 51. Brazil Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Parkinsons Disease Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Parkinsons Disease Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Parkinsons Disease Drug Production Market Share by Region (2019-2025)
Figure 62. North America Parkinsons Disease Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Parkinsons Disease Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Parkinsons Disease Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China Parkinsons Disease Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Parkinsons Disease Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Parkinsons Disease Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parkinsons Disease Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parkinsons Disease Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Parkinsons Disease Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Parkinsons Disease Drug Market Share Forecast by Application (2025-2032)
